open access

Vol 94, No 4 (2023)
Research paper
Published online: 2023-02-17
Get Citation

Novel marker to predict rupture risk in tubal ectopic pregnancies: the systemic immune-inflammation index

Kemal Dinc1, Gizem Issın2
·
Pubmed: 36929797
·
Ginekol Pol 2023;94(4):320-325.
Affiliations
  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey
  2. Department of Pathology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey

open access

Vol 94, No 4 (2023)
ORIGINAL PAPERS Obstetrics
Published online: 2023-02-17

Abstract

Objectives: Ectopic pregnancy is a life-threatening condition; delaying treatment can result in mortality or serious complications. Identification of a biomarker that can predict tubal rupture may be helpful for guiding treatment. In this study, we evaluated the association between serum β-hCG, biochemical markers, Systemic Immunity-inflammation Index (SII) score, and the trophoblastic invasion stage.
Material and methods: Tubal pregnancy was classified into three groups based on the depth of trophoblastic infiltration: stage I — limited to the mucosa; stage II — invaded the muscular layer, and stage III — invaded the serosa/subserosa of the tuba uterine. The association between groups, serum β-hCG, biochemical markers, and the SII score were assessed.
Results: There was no significant difference between the groups, hemoglobin, platelet count, MPV, RDW, NLR or PLR values (p > 0.05). A ROC analysis was performed to evaluate the accuracy of serum β-hCG predictions for infiltration level. At a 95% confidence interval upper limit, cut-off value of the serum β-hCG that best predicted stage III trophoblastic infiltration, was 2799 mIU/mL, with 78.9% sensitivity, 53.8% specificity (positive predictive value was 71.4%, and a negative predictive value was 63.6%). Moreover, ROC curve analysis showed that The SII value of 792 was the best predictor of trophoblastic infiltration at stage III, with a sensitivity of 92.3% and a specificity of 63.1%.
Conclusions: A linear relationship exists between depth of trophoblastic infiltration and serum β-hCG and the SII were observed. These findings suggested that the SII score can be used for predicting tubal ectopic pregnancy rupture.

Abstract

Objectives: Ectopic pregnancy is a life-threatening condition; delaying treatment can result in mortality or serious complications. Identification of a biomarker that can predict tubal rupture may be helpful for guiding treatment. In this study, we evaluated the association between serum β-hCG, biochemical markers, Systemic Immunity-inflammation Index (SII) score, and the trophoblastic invasion stage.
Material and methods: Tubal pregnancy was classified into three groups based on the depth of trophoblastic infiltration: stage I — limited to the mucosa; stage II — invaded the muscular layer, and stage III — invaded the serosa/subserosa of the tuba uterine. The association between groups, serum β-hCG, biochemical markers, and the SII score were assessed.
Results: There was no significant difference between the groups, hemoglobin, platelet count, MPV, RDW, NLR or PLR values (p > 0.05). A ROC analysis was performed to evaluate the accuracy of serum β-hCG predictions for infiltration level. At a 95% confidence interval upper limit, cut-off value of the serum β-hCG that best predicted stage III trophoblastic infiltration, was 2799 mIU/mL, with 78.9% sensitivity, 53.8% specificity (positive predictive value was 71.4%, and a negative predictive value was 63.6%). Moreover, ROC curve analysis showed that The SII value of 792 was the best predictor of trophoblastic infiltration at stage III, with a sensitivity of 92.3% and a specificity of 63.1%.
Conclusions: A linear relationship exists between depth of trophoblastic infiltration and serum β-hCG and the SII were observed. These findings suggested that the SII score can be used for predicting tubal ectopic pregnancy rupture.

Get Citation

Keywords

ectopic pregnancy; NLR; PLR; Systemic Immune-inflammation Index; trophoblastic invasion

About this article
Title

Novel marker to predict rupture risk in tubal ectopic pregnancies: the systemic immune-inflammation index

Journal

Ginekologia Polska

Issue

Vol 94, No 4 (2023)

Article type

Research paper

Pages

320-325

Published online

2023-02-17

Page views

2117

Article views/downloads

448

DOI

10.5603/GP.a2023.0010

Pubmed

36929797

Bibliographic record

Ginekol Pol 2023;94(4):320-325.

Keywords

ectopic pregnancy
NLR
PLR
Systemic Immune-inflammation Index
trophoblastic invasion

Authors

Kemal Dinc
Gizem Issın

References (16)
  1. Al Naimi A, Moore P, Brüggmann D, et al. Ectopic pregnancy: a single-center experience over ten years. Reprod Biol Endocrinol. 2021; 19(1): 79.
  2. Garcia Grau E, Checa Vizcaíno MÁ, Oliveira M, et al. The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy. Obstet Gynecol Int. 2011; 2011: 547946.
  3. Bouyer J, Coste J, Fernandez H, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002; 17(12): 3224–3230.
  4. Alkatout I, Honemeyer U, Strauss A, et al. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv. 2013; 68(8): 571–581.
  5. Dvash S, Cuckle H, Smorgick N, et al. Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2021; 259: 95–99.
  6. Karaman E, Çim N, Alkış İ, et al. Evaluation of mean platelet volume in unruptured ectopic pregnancy: A retrospective analysis. J Obstet Gynaecol. 2016; 36(5): 622–625.
  7. Artunc Ulkumen B, Pala HG, Calik E, et al. Can Mean Platelet Volume and Platelet Distrubition Width be Possible Markers for Ectopic Pregnancy and Tubal Rupture? (MPV and PDW in Ectopic Pregnancy). Pak J Med Sci. 2014; 30(2): 352–355.
  8. Tanacan A, Uyanik E, Unal C, et al. A cut-off value for systemic immune-inflammation index in the prediction of adverse neonatal outcomes in preterm premature rupture of the membranes. J Obstet Gynaecol Res. 2020; 46(8): 1333–1341.
  9. Elito J, Ferreira DF, Araujo Júnior E, et al. Values of beta-human chorionic gonadotrofin as a risk factor for tubal pregnancy rupture evaluated by histopathology. J Matern Fetal Neonatal Med. 2014; 27(6): 637–639.
  10. Walzik D, Joisten N, Zacher J, et al. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021; 121(7): 1803–1814.
  11. Turgut EN, Celik E, Celik S, et al. Could serum β-hCG levels and gestational age be the indicative factors for the prediction of the degree of trophoblastic invasion into tubal wall in unruptured ampullary pregnancies? Arch Gynecol Obstet. 2013; 287(2): 323–328.
  12. Turgut E, Yildirim M, Sakcak B, et al. Predicting miscarriage using systemic immune-inflammation index. J Obstet Gynaecol Res. 2022; 48(3): 587–592.
  13. Darkhaneh RF, Asgharnia M, Porkar NF, et al. Predictive value of maternal serum β-hCG concentration in the ruptured tubal ectopic pregnancy . Iran J Reprod Med. 2015; 13(2): 101–106.
  14. Walzik D, Joisten N, Zacher J, et al. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021; 121(7): 1803–1814.
  15. Shaw JLV, Dey SK, Critchley HOD, et al. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update. 2010; 16(4): 432–444.
  16. Turgut A, Sak ME, Ozler A, et al. Alteration of peripheral blood cells in tubal ectopic pregnancy. Ginekol Pol. 2013; 84(3): 193–196.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl